Literature DB >> 24878761

Function and regulation of the mono-ADP-ribosyltransferase ARTD10.

Max Kaufmann1, Karla L H Feijs, Bernhard Lüscher.   

Abstract

The transfer of ADP-ribose from NAD(+) to a substrate by ADP-ribosyltransferases, ADP-ribosylation, is a multifunctional posttranslational modification. While many studies have addressed the function of poly-ADP-ribosylation, for example, in DNA repair, signaling, and gene transcription, little is known about the role of mono-ADP-ribosylation. Recent work describing the mono-ADP-ribosyltransferase ARTD10/PARP10 suggests that this enzyme affects apoptosis, NF-κB signaling, and DNA damage repair, at least in part dependent on its activity as mono-ADP-ribosyltransferase. Moreover, the macrodomain-containing proteins MacroD1, MacroD2, and TARG1/C6orf130 were recently described as hydrolases, which remove mono-ADP-ribosylation thus providing evidence that this modification is reversible. In this review, we discuss these novel findings and their broader implications for cell behavior. We suggest functions of ARTD10 in immunity, metabolism, and cancer biology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24878761     DOI: 10.1007/82_2014_379

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  16 in total

Review 1.  Pyridine Dinucleotides from Molecules to Man.

Authors:  Joshua P Fessel; William M Oldham
Journal:  Antioxid Redox Signal       Date:  2017-07-25       Impact factor: 8.401

Review 2.  ADP-ribosyltransferases and poly ADP-ribosylation.

Authors:  Chao Liu; Xiaochun Yu
Journal:  Curr Protein Pept Sci       Date:  2015       Impact factor: 3.272

3.  PARP10 suppresses tumor metastasis through regulation of Aurora A activity.

Authors:  Yahui Zhao; Xiaoding Hu; Li Wei; Dan Song; Juanjuan Wang; Lifang You; Hexige Saiyin; Zhaojie Li; Wenbo Yu; Long Yu; Jin Ding; Jiaxue Wu
Journal:  Oncogene       Date:  2018-03-08       Impact factor: 9.867

4.  Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors.

Authors:  Ann-Gerd Thorsell; Torun Ekblad; Tobias Karlberg; Mirjam Löw; Ana Filipa Pinto; Lionel Trésaugues; Martin Moche; Michael S Cohen; Herwig Schüler
Journal:  J Med Chem       Date:  2016-12-21       Impact factor: 7.446

Review 5.  Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules.

Authors:  Maria Giulia Nizi; Mirko M Maksimainen; Lari Lehtiö; Oriana Tabarrini
Journal:  J Med Chem       Date:  2022-05-24       Impact factor: 8.039

6.  Integrating DNA-encoded chemical libraries with virtual combinatorial library screening: Optimizing a PARP10 inhibitor.

Authors:  Mike Lemke; Hannah Ravenscroft; Nicole J Rueb; Dmitri Kireev; Dana Ferraris; Raphael M Franzini
Journal:  Bioorg Med Chem Lett       Date:  2020-08-05       Impact factor: 2.823

Review 7.  Intracellular Mono-ADP-Ribosylation in Signaling and Disease.

Authors:  Mareike Bütepage; Laura Eckei; Patricia Verheugd; Bernhard Lüscher
Journal:  Cells       Date:  2015-09-25       Impact factor: 6.600

8.  PARP10 (ARTD10) modulates mitochondrial function.

Authors:  Judit Márton; Tamás Fodor; Lilla Nagy; András Vida; Gréta Kis; Attila Brunyánszki; Miklós Antal; Bernhard Lüscher; Péter Bai
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

9.  Cytoplasmic ADP-ribosylation levels correlate with markers of patient outcome in distinct human cancers.

Authors:  Fabio Aimi; Holger Moch; Peter Schraml; Michael O Hottiger
Journal:  Mod Pathol       Date:  2021-03-19       Impact factor: 7.842

10.  Atlantic salmon populations reveal adaptive divergence of immune related genes - a duplicated genome under selection.

Authors:  Erik Kjærner-Semb; Fernando Ayllon; Tomasz Furmanek; Vidar Wennevik; Geir Dahle; Eero Niemelä; Mikhail Ozerov; Juha-Pekka Vähä; Kevin A Glover; Carl J Rubin; Anna Wargelius; Rolf B Edvardsen
Journal:  BMC Genomics       Date:  2016-08-11       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.